Search Reports

Showing search results for "all"

Below you can search for information on drugs that are, or are likely, to go into shortage, or, be discontinued. A drug shortage means a situation in which a company is unable to meet the demand for a product. A discontinuation occurs when a company decides to stop selling a product.

A public access API (application program interface) is also available to access shortage and discontinuation report data in an alternative format. Access the API here.

The export is also available for download through an extract zip file that is updated monthly. Access the Monthly Report extract here.

To

Status Brand name Company Name Strength Last updated View Report
Actual shortage UROZIDE BIOMED PHARMA 2018-02-15 27905
Discontinued VAN-FLUOXETINE VANC PHARMACEUTICALS INC 2018-08-17 58371
Actual shortage UROZIDE BIOMED PHARMA 2017-11-02 27908
Discontinued ACT TADALAFIL ACTAVIS PHARMA COMPANY 2018-10-22 65284
Actual shortage UROZIDE BIOMED PHARMA 2017-11-02 27911
Discontinued ACT ESCITALOPRAM TEVA CANADA LIMITED 2018-10-17 64520
Actual shortage BIO-AMITRIPTYLINE BIOMED PHARMA 2018-02-20 27657
Discontinued ACT TADALAFIL ACTAVIS PHARMA COMPANY 2018-10-22 65289
Actual shortage UROZIDE BIOMED PHARMA 2017-11-02 27914
Discontinued ANDRIOL MERCK CANADA INC 2018-02-02 38155
Actual shortage BIO-AMITRIPTYLINE BIOMED PHARMA 2017-11-01 27660
Actual shortage UROZIDE BIOMED PHARMA 2017-11-02 27917
Discontinued ACT ESCITALOPRAM TEVA CANADA LIMITED 2018-10-17 64526
Actual shortage BIO-ATENOLOL BIOMED PHARMA 2017-11-01 27663
Discontinued VAN-GABAPENTIN VANC PHARMACEUTICALS INC 2018-08-17 58383
Resolved MINT-PRAVASTATIN MINT PHARMACEUTICALS INC 2018-01-31 27153
Discontinued ACT ESCITALOPRAM TEVA CANADA LIMITED 2018-10-17 64529
Actual shortage BIO-ATENOLOL BIOMED PHARMA 2017-11-01 27667
Discontinued TYPHERIX GLAXOSMITHKLINE INC 2017-12-22 34324
Discontinued ACT ESCITALOPRAM TEVA CANADA LIMITED 2018-10-17 64532

Showing 1 to 20 of 7760